List of bibliographic references
Number of relevant bibliographic references: 25.
[0-20] [
0 - 20][
0 - 25][
20-24][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000104 (2014) |
Z. Ding [États-Unis] ; M. Joy [États-Unis] ; R. Bhargava [États-Unis] ; M. Gunsaulus [États-Unis] ; N. Lakshman [États-Unis] ; M. Miron-Mendoza [États-Unis] ; M. Petroll [États-Unis] ; J. Condeelis [États-Unis] ; A. Wells [États-Unis] ; P. Roy [États-Unis] | Profilin-1 downregulation has contrasting effects on early vs late steps of breast cancer metastasis. |
| 000796 (2014) |
Vanessa W. Lim [Singapour] ; Jun Li [Singapour] ; Yinhan Gong [Singapour] ; Aizhen Jin [Singapour] ; Jian-Min Yuan [États-Unis] ; Eu Leong Yong [Singapour] ; Woon-Puay Koh [Singapour] | Serum estrogen receptor bioactivity and breast cancer risk among postmenopausal women |
| 000C25 (2014) |
Matthew J. Sikora ; Kristine L. Cooper ; Amir Bahreini ; Soumya Luthra ; Guoying Wang ; Uma R. Chandran ; Nancy E. Davidson ; David J. Dabbs ; Alana L. Welm ; Steffi Oesterreich | Invasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen response |
| 000F15 (2014) |
Eun-Ryeong Hahm ; Shivendra V. Singh | Diallyl trisulfide inhibits estrogen receptor-α activity in human breast cancer cells |
| 001095 (2014) |
Marion E. Joy [États-Unis] ; Laura L. Vollmer [États-Unis] ; Keren Hulkower [États-Unis] ; Andrew M. Stern [États-Unis] ; Cameron K. Peterson [États-Unis] ; R. C. Utch Boltz [États-Unis] ; Partha Roy [États-Unis] ; Andreas Vogt [États-Unis] | A High-Content, Multiplexed Screen in Human Breast Cancer Cells Identifies Profilin-1 Inducers with Anti-Migratory Activities |
| 001480 (2014) |
Donald P. Taylor ; Amanda Clark ; Sarah Wheeler ; Alan Wells | Hepatic nonparenchymal cells drive metastatic breast cancer outgrowth and partial epithelial to mesenchymal transition |
| 001767 (2014) |
Zhongmin Liu [États-Unis] ; Yun Zhan [République populaire de Chine] ; Yizeng Tu [États-Unis] ; Ka Chen [États-Unis] ; Zhihua Liu [République populaire de Chine] ; Chuanyue Wu [États-Unis] | PDZ and LIM domain protein 1(PDLIM1)/CLP36 promotes breast cancer cell migration, invasion and metastasis through interaction with α-actinin |
| 001A19 (2014) |
Nika C. Gloyeske [États-Unis] ; David J. Dabbs ; Rohit Bhargava | Low ER+ breast cancer: Is this a distinct group? |
| 001B15 (2014) |
Arumugam Nagalingam [États-Unis] ; Panjamurthy Kuppusamy [États-Unis] ; Shivendra V. Singh [États-Unis] ; Dipali Sharma [États-Unis] ; Neeraj K. Saxena [États-Unis] | Mechanistic elucidation of the antitumor properties of withaferin A in breast cancer |
| 001B89 (2014) |
D A Yardley [États-Unis] ; D. Tripathy [États-Unis] ; A M Brufsky [États-Unis] ; H S Rugo [États-Unis] ; P A Kaufman [États-Unis] ; M. Mayer [États-Unis] ; J. Magidson [États-Unis] ; B. Yoo [États-Unis] ; C. Quah [États-Unis] ; M. Ulcickas Yood [États-Unis] | Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER |
| 001D56 (2014) |
Rohit Bhargava [États-Unis] ; David J. Dabbs [États-Unis] | Interpretation of human epidermal growth factor receptor 2 (HER2) in situ hybridization assays using 2013 update of American Society of Clinical Oncology/College of American Pathologists HER2 Guidelines. |
| 001F93 (2014) |
Amanda M. Clark [États-Unis] ; Sarah E. Wheeler [États-Unis] ; Donald P. Taylor [États-Unis] ; Venkateswaran C. Pillai [États-Unis] ; Carissa L. Young [États-Unis] ; Rachelle Prantil-Baun [États-Unis] ; Transon Nguyen [États-Unis] ; Donna B. Stolz [États-Unis] ; Jeffrey T. Borenstein [États-Unis] ; Douglas A. Lauffenburger [États-Unis] ; Raman Venkataramanan [États-Unis] ; Linda G. Griffith [États-Unis] ; Alan Wells [États-Unis] | A Microphysiological System Model of Therapy for Liver Micrometastases |
| 001F97 (2014) |
Su-Hyeong Kim ; Shivendra V. Singh | Mammary Cancer Chemoprevention by Withaferin A Is Accompanied by In Vivo Suppression of Self-Renewal of Cancer Stem Cells |
| 002214 (????) |
Adam M. Brufsky [États-Unis] | Managing postmenopausal women with hormone receptor-positive advanced breast cancer who progress on endocrine therapies with inhibitors of the PI3K pathway. |
| 002239 (2014) |
Harold J. Burstein ; Sarah Temin ; Holly Anderson ; Thomas A. Buchholz ; Nancy E. Davidson ; Karen E. Gelmon ; Sharon H. Giordano ; Clifford A. Hudis ; Diana Rowden ; Alexander J. Solky ; Vered Stearns ; Eric P. Winer ; Jennifer J. Griggs | Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update |
| 002370 (2014) |
Hye-Yeong Kim ; Xiaolei Wang ; Brendon Wahlberg ; W. Barry Edwards | Discovery of Hapten-Specific scFv from a Phage Display Library and
Applications for HER2-Positive Tumor Imaging |
| 002376 (2014) |
Tadeu Ambros [États-Unis] ; Simon B. Zeichner ; John Zaravinos ; Alberto J. Montero ; Eugene Ahn ; Mani Aruna ; Lori Kronish ; Reshma L. Mahtani ; Charles L. Vogel | A retrospective study evaluating a fixed low dose capecitabine monotherapy in women with HER-2 negative metastatic breast cancer. |
| 002504 (2014) |
Tiffany A. Katz [États-Unis] ; Shauna N. Vasilatos ; Emily Harrington ; Steffi Oesterreich ; Nancy E. Davidson ; Yi Huang | Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells. |
| 002514 (2014) |
Beth Z. Clark [États-Unis] ; Surabhi Beriwal [États-Unis] ; David J. Dabbs [États-Unis] ; Rohit Bhargava [États-Unis] | Semiquantitative GATA-3 immunoreactivity in breast, bladder, gynecologic tract, and other cytokeratin 7-positive carcinomas. |
| 002A07 (2014) |
Sharon Wilks [États-Unis] ; Shannon Puhalla [États-Unis] ; Joyce O'Shaughnessy [États-Unis] ; Lee Schwartzberg [États-Unis] ; Erhan Berrak [États-Unis] ; James Song [États-Unis] ; David Cox [États-Unis] ; Linda Vahdat [États-Unis] | Phase 2, multicenter, single-arm study of eribulin mesylate with trastuzumab as first-line therapy for locally recurrent or metastatic HER2-positive breast cancer. |
| 002E99 (2014) |
G. Chen ; R. Gupta ; S. Petrik ; M. Laiko ; Jm Leatherman ; Jm Asquith ; Mm Daphtary ; E. Garrett-Mayer ; Ne Davidson ; K. Hirt ; M. Berg ; Jn Uram ; T. Dauses ; J. Fetting ; Em Duus ; S. Atay-Rosenthal ; X. Ye ; Ac Wolff ; V. Stearns ; Em Jaffee ; La Emens | A Feasibility Study of Cyclophosphamide, Trastuzumab, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for HER-2+ Metastatic Breast Cancer |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Breast Neoplasms (metabolism)"
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i \
-Sk "Breast Neoplasms (metabolism)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Amérique
|area= PittsburghV1
|flux= Ncbi
|étape= Curation
|type= indexItem
|index= KwdEn.i
|clé= Breast Neoplasms (metabolism)
}}
| This area was generated with Dilib version V0.6.38.
Data generation: Fri Jun 18 17:37:45 2021. Site generation: Fri Jun 18 18:15:47 2021 |  |
